Download Primary Postpartum Haemorrhage

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Postpartum infections wikipedia , lookup

Cell-free fetal DNA wikipedia , lookup

Prenatal testing wikipedia , lookup

Transcript
Primary Postpartum
Haemorrhage
Max Brinsmead MB BS PhD
May 2015
Introduction

The average gravida carries 1 - 1.5 l of
“extra blood” in pregnancy as prophylaxis
against PPH but…

PPH is still the major cause of obstetric
death especially in developing countries

10 - 15% of women lose >600 ml of blood at
delivery and…

For 1 - 2% the blood loss can be life
threatening
This presentation will address…

Current guidelines for the management of
the third stage of labour and their evidence
base

Emergency (First aid) and

Advanced Measures for the management of
excessive blood loss in the first 24 hours
after birth
From the Cochrane
Database

Active vs Expectant Management of the 3rd
stage of labour
• Now withdrawn as out of date

Oxytocin vs Ergometrine

Oxytocin vs Prostaglandins

Uterine massage in preventing PPH
Active vs Expectant Management
of 3rd Stage Labour


4 studies - all in the UK
Active management associated with:

Reduced blood loss (-79 ml, CI 64-94 mls less)

Fewer PPH >500 ml (OR=0.34, CI 0.28-0.41)

Shorter 3rd stage (-3.4 min, CI 4.66-2.13 min
less)
Active vs Expectant Management
of 3rd Stage Labour
For the individual patient this may mean:
If she declines the administration of an oxytocic
drug she has a 1:6 chance of losing >500 ml
blood
If she has an oxytocic drug this is reduced to a
1:20 chance of losing >500 ml blood
Active vs Expectant Management
of 3rd Stage Labour
Active management is associated with:


Increased rate of maternal nausea &
vomiting (OR 1.95, CI 1.58 - 2.42)
Increased rate of maternal hypertension
Delayed vs Early (within 60
sec) Cord Clamping
Is associated with:
 No difference in the rate of PPH (RR 1.22 CI
0.96–1.55)

Increased rates of jaundice requiring
phototherapy

Neonatal advantages in terms of Hb levels
and Ferritin up to 6 months of age
NICE Guidelines (2007) for
management of the 3rd Stage

Active management is recommended i.e.
• IM Oxytocin 10 IU
• Early cord clamping
• Cord traction


Women at low risk of PPH who elect to have physiological
management should have their choice respected
Active management is required if
• There is PPH
• The placenta is not delivered within 60 min
• Patient requests earlier intervention

Cord traction and uterine palpation should only be used after an
oxytocic has been given
Syntometrine vs Syntocinon
for 3rd Stage Labour

Use of Syntometrine results in:

Fewer PPHs (OR 0.74, CI 0.65-0.85)

BUT
More vomiting
 Greater risk maternal hypertension
 And greater risk of retained placenta

Prostaglandins for the
Prevention of PPH
Injected PG s resulted in:







Reduced mean blood loss
Shorter 3rd stage
Non sigificant reduction in rate PPH but…
Shivering (almost 20%)
Diarrhoea
Abdominal pain
Increased cost
Rectal Misoprostol

PPH rate reduced from 7.0% to 4.8% (not
significant in the study reported) but

Fewer side effects than after IM or oral use
of PG’s

This drug is cheap and stable and could
have an enormous impact on maternal
mortality in developing countries
Carbetocin
Danseraua et al Am J Obstet Gynecol March 99




694 women in a Canadian multicentre trial
One dose Carbetocin 100 ug cf 8 hour
Oxytocin infusion
Outcome studied “additional oxytocic
required”
Fewer patients requiring additional oxytocic
after Carbetocin (OR = 2.03, CI 1.1 - 2.8)
Uterine massage after
delivery of the placenta…






Only one study of 200 patients and that was with
active management of 3rd stage:
The rate of PPH was halved but not statistically
significant
BUT
Mean blood loss reduced by massage (-42 ml CI -8
to -75)
Reduced need for extra oxytocic (RR 0.20 CI 0.080.50)
2 transfusions required in the no massage group
Also from the Cochrane
Database

No benefit from cord drainage

No benefit from umbilical vein injection of
oxytocic

No benefit from early suckling

Chinese traditional medicine report pending
Risk factors for Primary PPH













Prolonged labour
APH
Pre eclampsia
Maternal obesity
Multiple pregnancy
Birth weight >4000g
Advanced maternal age
Previous PPH
Assisted delivery
Low lying placenta
But >50% occur in women without identified risk
factors and…
90% are associated with uterine atony
And all studies of massive PPH fail to identify
consistent risk factors
Patient Assessment
Objective measure of blood loss is desirable
 Postural hypotension the earliest sign
 Tachycardia is usual
 Air hunger and loss of consciousness is
serious
 Urine output a good measure of treatment
 CVP sometimes
 A bedside test of blood clotting desirable

Emergency Measures


Rub up a contraction
Deliver the placenta
• If you can


Gain IV access (large bore cannula)
Additional oxytocic
• IV Ergometrine 0.25 mg
• Syntocinon infusion
• Rectal Cervagem or Misoprostol



(Empty the bladder)
Bimanual uterine compression
Aortic compression
Advanced Measures 1
Get help
 Check coagulation - use
cryoprecipitate etc.
 EUA is mandatory
 Myometrial PG F2 alpha
 Uterine Packing

• Intrauterine balloon catheter

Consider activated Factor VII
Intrauterine Balloon Tamponade
BJOG Review May 2009
 Was effective in 91.5% of cases
• Combined retrospective and prospective studies
• But only a total of 106 patients

Types of balloons
•
•
•
•
•

Sengstaken Blakemore (GI use)
Rusch (Urological)
Foley (often multiple)
Bakri (Specifically designed for obstetrics)
Condom (+/- Foley)
But there remain many unanswered
questions
Questions concerning intrauterine balloon
tamponade
BJOG Review May 2009
 Is it effective
• There are no RCTs
Risks and contraindications
 Which balloon to use, how to insert it
and what volume to inflate it
 Is a vaginal pack required
 Is an oxytocin infusion required
 Antibioitics and analgesia
 When to deflate and or remove it

Advanced Measures 2

Get more help
• Medical – haematologist
• Surgical colleague
• Radiologist for…


Uterine artery embolisation
Laparotomy and…




B-Lynch suture
Internal iliac artery ligation
Aortic clamping
Hysterectomy
Any Questions or
Comments?
Please leave a note on the Welcome
Page to this website